Cancel
Dallan Murray
Executive Vice President, Chief Customer Officer
@
Sarepta Therapeutics
514l6k9@vkk9qzj.9f3
Sign up to see email
Known information
- Was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine
About Sarepta Therapeutics
Sarepta Therapeutics is a biotechnology company specializing in precision genetic medicine for rare diseases, with over 40 investigational therapies and FDA-approved treatments for Duchenne muscular dystrophy.
Report inaccurate information
